Exponent, Inc. (NASDAQ:EXPO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The firm currently has a $81.00 price target on the business services provider’s stock. Zacks Investment Research‘s price objective indicates a potential upside of 11.96% from the company’s current price.
According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
A number of other research analysts have also recently issued reports on the company. Cantor Fitzgerald reiterated a “buy” rating and set a $75.00 price objective (up previously from $69.00) on shares of Exponent in a research note on Wednesday, July 19th. BidaskClub cut Exponent from a “sell” rating to a “strong sell” rating in a research note on Tuesday, June 27th. ValuEngine upgraded Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. Finally, SunTrust Banks, Inc. reiterated a “hold” rating and set a $77.00 price objective on shares of Exponent in a research note on Thursday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $80.00.
Shares of Exponent (EXPO) opened at 72.35 on Friday. Exponent has a one year low of $55.69 and a one year high of $77.15. The company’s 50-day moving average price is $72.72 and its 200 day moving average price is $64.21. The company has a market cap of $1.87 billion, a P/E ratio of 37.51 and a beta of 0.61.
Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Wednesday, October 18th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.09. The business had revenue of $87.60 million during the quarter, compared to analysts’ expectations of $79.69 million. Exponent had a return on equity of 17.21% and a net margin of 16.46%. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.42 earnings per share. On average, equities research analysts anticipate that Exponent will post $2.09 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Exponent, Inc. (EXPO) Stock Rating Upgraded by Zacks Investment Research” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://stocknewstimes.com/2017/10/22/exponent-inc-expo-stock-rating-upgraded-by-zacks-investment-research.html.
In other Exponent news, CEO Paul R. Johnston sold 3,052 shares of Exponent stock in a transaction on Tuesday, September 26th. The stock was sold at an average price of $73.11, for a total value of $223,131.72. Following the completion of the sale, the chief executive officer now owns 35,342 shares of the company’s stock, valued at approximately $2,583,853.62. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Paul R. Johnston sold 3,000 shares of Exponent stock in a transaction on Friday, September 29th. The stock was sold at an average price of $74.01, for a total value of $222,030.00. Following the completion of the sale, the chief executive officer now directly owns 32,342 shares of the company’s stock, valued at approximately $2,393,631.42. The disclosure for this sale can be found here. In the last three months, insiders sold 79,593 shares of company stock valued at $5,343,437. Corporate insiders own 2.80% of the company’s stock.
Several institutional investors have recently bought and sold shares of EXPO. Riverhead Capital Management LLC increased its holdings in shares of Exponent by 89.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 1,897 shares of the business services provider’s stock worth $111,000 after purchasing an additional 897 shares in the last quarter. Advisor Group Inc. increased its holdings in shares of Exponent by 15.4% in the 2nd quarter. Advisor Group Inc. now owns 2,131 shares of the business services provider’s stock worth $124,000 after purchasing an additional 284 shares in the last quarter. Ameritas Investment Partners Inc. bought a new stake in shares of Exponent in the 1st quarter worth $132,000. Victory Capital Management Inc. increased its holdings in shares of Exponent by 9.2% in the 1st quarter. Victory Capital Management Inc. now owns 2,683 shares of the business services provider’s stock worth $160,000 after purchasing an additional 226 shares in the last quarter. Finally, Bank of Montreal Can increased its holdings in shares of Exponent by 0.7% in the 2nd quarter. Bank of Montreal Can now owns 3,231 shares of the business services provider’s stock worth $189,000 after purchasing an additional 22 shares in the last quarter. 88.29% of the stock is owned by institutional investors and hedge funds.
Exponent Company Profile
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.